On July 16, 2026, the New Jersey Supreme Court issued a precedential ruling holding that the state’s 2023 False Claims Act Opposition Amendment applies retroactively to pending litigation. The court determined that
Andy Burnham has confirmed he was fully aware of John Healey’s demands for significantly higher defence spending when he appointed him as Chancellor. The new Prime Minister told the BBC that ensuring
More
Alabama’s long-running medical cannabis licensing saga reaches a significant milestone as formal evidentiary hearings for integrated facility licences open in Tuscaloosa on Monday, July 27, 2026. The Alabama Medical Cannabis Commission’s designated
More
HSF Kramer has reported $2.407 billion in revenue for the financial year ending April 30, marking its first full set of annual results since combining operations in June 2025. The merged firm
More
JD Sports Fashion (LSE: JD) has staged a notable comeback, with shares climbing 36% over the past three months after years of painful underperformance. The FTSE 100-listed sportswear and athleisure retailer, which
More
The Bank of England is widely expected to hold interest rates unchanged at 3.75 per cent when its Monetary Policy Committee meets on Thursday. The decision is anticipated to result in a
More
Summit Therapeutics has released updated overall survival data from its phase 3 HARMONi trial as the FDA moves toward a landmark decision on ivonescimab. The new analysis, based on a data cut-off
More
The U.S. Court of Appeals for the Second Circuit has ruled that employees must show an adverse employment decision was motivated by their need for religious accommodation to establish a prima facie
More
Kim Kardashian has launched a new campaign for her brand UPDATE, leaning into her well-publicised struggles with the bar exam as a marketing tool. Rather than hiding from the joke, Kardashian has
More
Johnson & Johnson remains one of the most closely watched stocks on Wall Street, with retail and institutional investors alike tracking every major analyst and media recommendation. Jim Cramer, the well-known host
More
Samsung Biologics (KRX: 207940) has announced plans to acquire Swiss peptide manufacturer PolyPeptide in a deal worth approximately $1.8 billion, marking a landmark moment for South Korean biopharma. The transaction is described
More